Trial Profile
A Phase 1 Trial of PD0332991 and Paclitaxel in Patients With Rb-Expressing Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions; Biomarker
- 07 Apr 2020 Status changed from active, no longer recruiting to completed.
- 11 Jan 2019 Results published in the Clinical Cancer Research
- 18 Jul 2016 Status changed from completed to active, no longer recruiting.